Raloxifene News and Research

RSS
Raloxifene is an oral selective estrogen receptor modulator (SERM) that has oestrogenic actions on bone and anti-oestrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
Why estrogenic hormones produce unintended results in women

Why estrogenic hormones produce unintended results in women

Many women at high risk for breast cancer are foregoing tamoxifen

Many women at high risk for breast cancer are foregoing tamoxifen

Study indicates potential of alendronate and estrogen progression of osteoarthritis

Study indicates potential of alendronate and estrogen progression of osteoarthritis

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

Stress may increase risk for the most common type of uterine cancer

Stress may increase risk for the most common type of uterine cancer

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

North America's largest-ever breast cancer enrolls 19,000th participant

North America's largest-ever breast cancer enrolls 19,000th participant